Form 144: UBS Financial Services lists proposed PCVX share sales

UBS Financial Services, Inc. submitted a Form 144 notice reporting proposed sales of Common stock tied to option exercises and vested RSUs.

Rhea-AI Filing Summary

UBS Financial Services, Inc. submitted a Form 144 notice reporting proposed sales of Common stock tied to option exercises and vested RSUs. The filing lists specific blocks of shares (e.g., 7,751, 5,548, 3,612, 5,325, 2,000, and 225) with transaction dates including 06/18/2026, 09/02/2024, 08/31/2024, 02/28/2025, and 03/02/2025.

The notice identifies the transactions as sales "by issuer" events on NASDAQ and includes prior issuer-issued founder shares and RSU vesting items. Timing and aggregate proceeds are not stated in the excerpt.

Insights

Securities Counsel

Form 144 lists proposed sales tied to option exercises and RSU vesting; no aggregate proceeds shown.

The filing enumerates discrete share lots (for example, 7,751 and 2,000) and labels the transactions as related to issuer-originated awards and an option exercise on 06/18/2026. This is a procedural notice required when restricted or control securities are proposed to be sold.

Effect on shareholders depends on whether these registrations result in market transactions; timing and aggregate proceeds are not provided in the excerpt, so cash‑flow treatment is not disclosed here.

Key Figures

Form date listed: 06/18/2026 RSU vest lot: 7,751 shares RSU vest lot: 5,548 shares +5 more

8 metrics

Form date listed 06/18/2026 transaction date referenced for option exercise

RSU vest lot 7,751 shares RSU Vest on 09/02/2024

RSU vest lot 5,548 shares RSU Vest on 08/31/2024

RSU vest lot 3,612 shares RSU Vest on 02/28/2025

RSU vest lot 5,325 shares RSU Vest on 03/02/2025

Founder shares 2,000 shares Founder Shares dated 12/09/2013

Option exercise lot 225 shares Exercise of stock options on 06/18/2026

Numeric identifiers 1284204.75; 144397682; 24461 filing fields shown in excerpt

Key Terms

Form 144, RSU Vest, Exercise of stock options, Founder Shares

4 terms

Form 144 regulatory

"submitted a Form 144 notice reporting proposed sales"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Vest financial

"Common | 09/02/2024 | RSU Vest | Issuer"

Exercise of stock options financial

"Common | 06/18/2026 | Exercise of stock options"

Founder Shares financial

"Common | 12/09/2013 | Founder Shares | Issuer"

Founder shares are the ownership stakes given to the people who start a company, often with extra voting power or protections compared with ordinary shares. For investors, they matter because founders’ control and incentives influence decisions about strategy, hiring, and whether the company sells or stays independent — like a family that keeps majority voting rights in a household decision. High founder ownership can mean stable leadership but also a risk that outside shareholders have less influence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the PCVX Form 144 filed by UBS Financial Services report?

It reports proposed sales of Common shares tied to option exercises and vested RSUs, listing individual lot sizes such as 7,751 and 2,000. The filing is a procedural notice of intended resale under securities rules.

Which share lots are listed in the filing for PCVX?

The excerpt lists share lots including 7,751, 5,548, 3,612, 5,325, 2,000, and 225, with associated dates like 09/02/2024 and 06/18/2026. These appear tied to RSU vesting and an option exercise.

Does the Form 144 for PCVX state aggregate proceeds or pricing?

No. The provided excerpt lists share counts and transaction dates but does not disclose any aggregate proceeds, sale prices, or underwriting terms in the visible content.

Are the listed securities registered for resale in the excerpt?

The document is a Form 144 notice of proposed sale of restricted/control stock. The excerpt lists items to be sold but does not show a registration statement or aggregate registered amount in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:11 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001258693
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vaxcyte, Inc.
SEC File Number	001-39323
Address of Issuer	825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CALIFORNIA 94070
Phone	650-837-0111
Name of Person for Whose Account the Securities are To Be Sold	PICKERING GRANT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 1000 Harbor Boulevard Weehawken NJ 07016	24461	1284204.75	144397682	06/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/18/2026	Exercise of stock options	Issuer			225	06/18/2026	Cash
Common	09/02/2024	RSU Vest	Issuer			7751	09/02/2024	NA
Common	08/31/2024	RSU Vest	Issuer			5548	08/31/2024	NA
Common	02/28/2025	RSU Vest	Issuer			3612	02/28/2025	NA
Common	03/02/2025	RSU Vest	Issuer			5325	03/02/2025	NA
Common	12/09/2013	Founder Shares	Issuer			2000	12/09/2013	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	22,461 shares represented in this filing are being sold under Grant Pickering, 1,000 shares are being sold under the Claire Pickering 2020 Delaware Trust and 1,000 shares are being sold under the Benjamin Pickering 2020Delaware Trust.
Date of Notice	06/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Grant Pickering
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)